SenesTech, Inc.SNES決算レポート
Nasdaq · 産業 · 農薬
SenesTechは農業バイオテクノロジー・ライフサイエンス企業で、繁殖制御による害獣駆除を専門としています。同社の主力製品ContraPestは、ドブネズミとクマネズミの不妊化を実現し、害鼠の個体数を抑制する製品で、本社は米国アリゾナ州フェニックスに置かれています。
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| PFS Cap Mgt Co | 9.99% | 95.0K | — | 2024-11-12 |
| Nos. of above persons | 9.90% | 92.5K | ▲ +9.90pp | 2024-11-14 |
| Armistice Capital, LLC | 4.99% | 117.4K | — | 2024-02-14 |
インサイダー取引
Net 90d: +$697.5K · buys $697.5K / sells $0期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-03-17 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 19.7K | $1.79 | $35.4K |
| 2026-03-16 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 5.1K | $1.86 | $9.4K |
| 2026-03-13 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 146.2K | $1.95 | $285.4K |
| 2026-02-19 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 34.6K | $2.40 | $83.1K |
| 2026-02-18 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 10.5K | $2.29 | $24.0K |
| 2026-02-17 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 40.8K | $2.29 | $93.5K |
| 2026-02-13 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 15.4K | $1.89 | $29.1K |
| 2026-02-12 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 8.0K | $1.72 | $13.7K |
| 2026-02-11 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 8.0K | $1.73 | $13.9K |
| 2026-02-05 | GLENBROOK CAPITAL MANAGEMENT | 10% Owner | Buy (open market) | 2.9K | $1.77 | $5.1K |
1–10 of 13
1 / 2 ページ